Tag: clinical trials
-
African Health Official Denounces U.S. Human-Experimentation Plans in Africa
Overview A leading health official from Africa has publicly criticized assertions that the United States government was considering human experimentation in African nations. The remarks come amid a broader global debate about ethics, consent, and the safety of medical research conducted across borders. The Africa Centres for Disease Control and Prevention (Africa CDC) has been…
-
Scientists Uncover Plant Secret That Could Help Fight Cancer
Nature’s Pharmacy: How Plants Are Shaping Modern Cancer Research For centuries, humans have looked to the plant kingdom for remedies to ailments big and small. Today, scientists are translating that ancient wisdom into rigorous, evidence-based medicine. A new wave of research is shedding light on a plant secret — a biochemical pathway that could bolster…
-
RFK Jr Vaccine Trial in Guinea-Bissau Blocked by Health Officials
Background: A Controversial Proposal The idea that a high-profile activist and author would spearhead a vaccine trial in a low-income country has raised eyebrows in global health circles. RFK Jr., a figure known for outspoken skepticism of vaccines and public health policy, proposed advancing a hepatitis B vaccine study in infants in Guinea-Bissau, a West…
-
RFK Jr. Vaccine Test in West Africa Blocked Amid Ethics Firestorm
Overview: A Controversial Vaccine Trial Comes Under Scrutiny The West African nation of Guinea-Bissau has suspended a US-funded study involving the hepatitis B vaccine in newborns. The decision, driven by a rising chorus of public health researchers and ethicists, centers on concerns about how the trial was designed, informed consent standards, and potential risks to…
-
Call for Applications: Data and Safety Monitoring Board (DSMB) Training by Africa CDC
Overview of the DSMB Training Opportunity The Africa Centres for Disease Control and Prevention (Africa CDC) invites qualified applicants to apply for the Data and Safety Monitoring Board (DSMB) Training. This program is designed to equip emerging health professionals with the principles and best practices for independent oversight of clinical trials and other health research.…
-
Call for Applications: DSMB Training by Africa CDC
Call for Applications: DSMB Training by Africa CDC The Africa Centres for Disease Control and Prevention (Africa CDC) has issued a call for applications to join its Data and Safety Monitoring Board (DSMB) training program. This initiative is designed to build expertise in the oversight and governance of health research, with a focus on safeguarding…
-
Call for Applications: DSMB Training for Africa CDC Scholars
Overview: Elevating Clinical Trial Safety with the DSMB Training The Africa Centres for Disease Control and Prevention (Africa CDC) has issued a call for applications to participate in its Data and Safety Monitoring Board (DSMB) training program. This initiative is designed to strengthen the capacity of member states and regional partners to oversee clinical trials…
-
Bamboo Shoots and Metabolic Health: Promise and Evidence
Overview: Bamboo Shoots as a Potential Metabolic Ally Bamboo-based foods, particularly bamboo shoots, have long been part of traditional cuisines around the world. Recent reviews synthesize available data to assess whether these foods could support metabolic health by offering dietary fiber, micronutrients, and unique phytochemicals. The central question is whether bamboo shoots can meaningfully influence…
-
Bamboo Shoots for Metabolic Health: Potential and Safety
Overview: Bamboo shoots as a candidate for metabolic health Bamboo shoots have captured interest as a nutrient-dense, sustainable food option. A growing body of research weighs their potential to support metabolic health—factors like blood sugar control, lipid profiles, and inflammatory markers—against the realities of limited human data and questions about safety. While laboratory studies and…
-
D3 Bio Secures FDA Clearance for Two INDs, Jumpstarting Phase 1 and Phase 2 Trials
FDA Clears Two INDs for D3 Bio, Launching Key Clinical Trials Shanghai-based D3 Bio, a clinical-stage biotechnology company focused on transformative oncology therapies, has announced that the U.S. Food and Drug Administration (FDA) has cleared two Investigational New Drug (IND) applications. The approvals enable a Phase 1 clinical trial for D3S-003 and a Phase 2…